Joseph Thome
Stock Analyst at TD Cowen
(4.77)
# 618
Out of 5,162 analysts
442
Total ratings
49.7%
Success rate
14.9%
Average return
Main Sectors:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: TEVA Teva Pharmaceutical Industries Limited | Reiterated: Buy | ILA 17,901 → ILA 18,551 | ILA 13,920 | +33.27% | 2 | Nov 12, 2026 | |
| TRDA Entrada Therapeutics | Reiterated: Buy | n/a | $5.03 | - | 16 | Nov 5, 2026 | |
| UTHR United Therapeutics | Rated: Buy | $675 → $700 | $577.34 | +21.25% | 33 | Nov 5, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $10 | $3.12 | +220.51% | 24 | Nov 4, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $300 | $247.77 | +21.08% | 32 | Nov 3, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $145 | $92.49 | +56.77% | 13 | Nov 3, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $315 → $135 | $134.00 | +0.75% | 36 | Nov 2, 2026 | |
| AZR Azora Therapeutics | Reiterated: Buy | n/a | $3.80 | - | 1 | Nov 2, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $90 → $95 | $60.23 | +57.73% | 49 | Oct 30, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | n/a | $3.82 | - | 11 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.40 | - | 17 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $37.75 | - | 18 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.77 | - | 22 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.30 | - | 28 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.11 | - | 9 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $47.06 | - | 25 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.62 | - | 8 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.76 | - | 9 | Aug 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.90 | - | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.6318 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.40 | - | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.12 | - | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $58 | $46.85 | +23.80% | 21 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.87 | - | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.65 | - | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.44 | n/a | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.49 | n/a | 9 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 5 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $195.85 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $10.74 | n/a | 1 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $146.58 | n/a | 1 | Oct 1, 2020 |
Teva Pharmaceutical Industries Limited
Nov 12, 2026
Reiterated: Buy
Price Target: ILA 17,901 → ILA 18,551
Current: ILA 13,920
Upside: +33.27%
Entrada Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.03
Upside: -
United Therapeutics
Nov 5, 2026
Rated: Buy
Price Target: $675 → $700
Current: $577.34
Upside: +21.25%
Ardelyx
Nov 4, 2026
Reiterated: Buy
Price Target: $10
Current: $3.12
Upside: +220.51%
Jazz Pharmaceuticals
Nov 3, 2026
Reiterated: Buy
Price Target: $300
Current: $247.77
Upside: +21.08%
Mirum Pharmaceuticals
Nov 3, 2026
Reiterated: Buy
Price Target: $145
Current: $92.49
Upside: +56.77%
Axsome Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: $315 → $135
Current: $134.00
Upside: +0.75%
Azora Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.80
Upside: -
PTC Therapeutics
Oct 30, 2026
Reiterated: Buy
Price Target: $90 → $95
Current: $60.23
Upside: +57.73%
Prime Medicine
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.82
Upside: -
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.40
Upside: -
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.75
Upside: -
Sep 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.77
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.30
Upside: -
Aug 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $43.11
Upside: -
Aug 25, 2026
Rated: Buy
Price Target: n/a
Current: $47.06
Upside: -
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.62
Upside: -
Aug 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.76
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.90
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.6318
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.40
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.12
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $57 → $58
Current: $46.85
Upside: +23.80%
Jul 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $15.87
Upside: -
May 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.65
Upside: -
Nov 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.44
Upside: n/a
Jul 19, 2024
Rated: Hold
Price Target: n/a
Current: $15.49
Upside: n/a
Oct 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $40
Current: $195.85
Upside: n/a
Oct 10, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $10.74
Upside: n/a
Oct 1, 2020
Reiterated: Buy
Price Target: n/a
Current: $146.58
Upside: n/a